ACQUIRED · 2019
Who Acquired CardioCel and VascuCel Biologic Patches (Admedus)?
LeMaitre Vascular Inc. · $17.4M
The acquisition
CardioCel and VascuCel Biologic Patches (Admedus) was acquired by LeMaitre Vascular Inc. in 2019 for $17.4M. at 2.50× revenue.
CardioCel and VascuCel Biologic Patches (Admedus) at time of acquisition
Revenue
$7.1M
Deal value
$17.4M
Other acquisitions by LeMaitre Vascular Inc.
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Artegraft Inc. · 2020 · $72.9M
- Applied Medical Resources Blood Clot Business · 2018 · $14.0M
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from SEC filings and press releases. Full deal page.
Citation: ExitValue.ai. (2019). CardioCel and VascuCel Biologic Patches (Admedus) acquired by LeMaitre Vascular Inc.. https://exitvalue.ai/acquired/cardiocel-and-vascucel-biologic-patches-admedus